US Patent Issued to UCB Biopharma on June 9 for "Substituted tetrahydroisoquinoline derivative as a D1 positive allosteric modulator" (Belgian Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,726, issued on June 9, was assigned to UCB Biopharma SRL (Brussels).

"Substituted tetrahydroisoquinoline derivative as a D1 positive allosteric modulator" was invented by Claude Delatour (Brussels).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to compound according to formula (I) which is a positive allosteric modulator of D1 and accordingly of benefit as pharmaceutical agent for the treatment of diseases in which D1 receptors play a role."

The patent was filed on Dec. 16, 2021, under Application No. 18/267,331.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/...